Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Authors
Discussion
Loading...
Member takes
Implication
Randomized trial examines noninvasive criteria for diagnosing cardiac ATTR amyloidosis, suggesting improved accuracy without histology.
Key Points
- The aim is to establish a reliable noninvasive diagnostic method for cardiac ATTR amyloidosis without histology.
- Utilized bone scintigraphy for diagnosis.
- Developed noninvasive diagnostic criteria.
- Focused on patients without monoclonal gammopathy.
- Diagnosis made reliably without histology.
- Criteria applicable to the majority of ATTR amyloidosis patients.
- Improved diagnosis may enhance patient outcomes.
Cite This Study
Gillmore et al. (2016) studied this question.